Revised in May 2022
① Requirements for submission of case reports are identical to those applied to original articles unless they are mentioned below:
② The manuscript should be in the following sequence: title page (Korean and English, author), abstract (Korean and English) and keywords, introduction, case description, discussion, references, figures and figure legends.
③ Korean summary must be in a structured form in which each paragraph starts with the headings - purpose (or introduction), case summary, and conclusions (can be omitted) typed in bold style. The summary section should be brief and specific and not exceed 600 words, including space between words.
④ Abstract in English should be concise less than 250 words and provide an overview of summary in Korean. Abstract must be in a structured form in which each paragraph starts with headings - Purpose (or Introduction), Case Summary and Conclusion (can be omitted) typed in bold style.
⑤ Up to five keywords representing the main content of the article should be listed in alphabetical order. The first letter of each word should be capitalized.
⑥ The main sections of case report (introduction, case, discussion and reference) except title, Korean summary, abstract in English and figures should be submitted on no more than A4 8 pages and typed using 10 point font size.
⑦ Manuscripts that meet one of the following conditions will be considered.
- A rare illness was handled.
- Abnormal symptoms were presented.
- A new diagnosis or treatment was provided.
- The case is the first of its kind in Korea.
- Culture-specific symptoms were presented.
- The case has an academic significance.
⑧ The number of all the references should be written on no more than 15, and less than 4 in figures.
ex) one author: Kim , two authors: Kim and Park , Three or more: Kim et al. 
ex, 1) less than 4 numbers of author
Lee JM, Hwang KY, Hwang HS, Kim MS. Long term clinical results of penetrating keratoplasty for macular corneal dystrophy. J Korean Ophthalmol Soc 2012;53:1425-31.
ex, 2) more than 5 numbers of author
Bonnet PO, Mason R, Single RL, et al. Hereditary retinal dystrophy. Am J Ophthalmol 1996;122:651-61.
ex, 1): In case of Book - Miller NR. Walsh and Hoyt’s Clinical Neuro-Ophthalmology, 4th ed. Vol. 4. Baltimore: Williams & Wilkins, 1991;2102-14.
ex, 2): A part of book (chapter) - Parks MM, Mitchell PR. Cranial nerve palsies. In: Tasman W, Jaeger EA, eds. Duane’s Clinical Ophthalmology, revised ed. Philadelphia: JB Lippincott, 1993; chap. 19.
ex, 1) Committee on Publication Ethics. Guidelines for retracting articles [Internet]. Committee on Publication Ethics; 2009 [cited 2013 Sep 20]. Available from: http://publicationethics.org/files/retraction%20guidelines.pdf.
ex, 2) DOI journal - Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev. 2002;(2):CD001054. doi:10.1002/14651858.CD1001054.
ex, 3) Monograph in electronic format - Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Etiology of the cell [CD-ROM]. 4th ed. New York, NY: Garland Science, 2002.
|Average Roughness (Ra)||RMS* Roughness (Rq)|
|Conventional||Cosmetic||p - value†||Conventional||Cosmetic||p - value†|
ex, 1) In case of drug: 1% prednisolone acetate (Predforte®, Allergan Inc., Irvine, CA, USA)
ex, 2) In case of instrument or device: Optical coherence tomography (Cirrus™ HD-OCT Model 400, Carl Zeiss Meditec, Jena, Germany)
ex) 2 kg (O), 2kg (X), 3/15 (O), 20-30 (O), 5:6 (O), 50% (O), 50° (O), 36°C (O).
ex) Colored photos cannot be transformed into black and white photographic prints.